Core Laboratories (CLB) Other financing activities (2022 - 2025)

Core Laboratories has reported Other financing activities for 4 years, with the latest figure at -$254000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other financing activities fell 106.76% year-over-year to -$254000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 77.95% YoY), and the FY2025 full-year result was -$254000.0, down 106.76% from the prior year.
• Other financing activities for Q4 2025 stood at -$254000.0, down from $1.3 million in the prior quarter.
• The five-year high for Other financing activities was $12.7 million in Q4 2023, with the low at -$7.0 million in Q4 2022.
• Historically, Other financing activities has averaged $1.6 million across 4 years, with a median of $1.3 million in 2025.
• The largest YoY upside for Other financing activities was 2519.57% in 2024 against a maximum downside of 122.96% in 2024.
• Core Laboratories' Other financing activities stood at -$7.0 million in 2022, then soared by 280.66% to $12.7 million in 2023, then plunged by 70.48% to $3.8 million in 2024, then tumbled by 106.76% to -$254000.0 in 2025.
• The last three Other financing activities figures came in at -$254000.0 (Q4 2025), $1.3 million (Q3 2025), and $539000.0 (Q2 2025), per Business Quant data.